Overview

The first comprehensive review of both the theory and practice of suicide gene therapy. The authors cover all the major aspects of suicide gene therapy, including the design and use of vectors in gene transduction, various enzyme and prodrug systems, the mechanistic analysis of the bystander effect, the design and synthesis of prodrugs, immunological implications, and its clinical impact. They also describe all the cutting-edge methods needed to explore, study, and advance understanding of the basic biology underlying gene therapy. Each fully tested method includes step-by-step instructions, a discussion of the principle behind the technique, equipment and reagent lists, tips on troubleshooting and avoiding pitfalls, and notes on the interpretation and use of results.

Full Product Details

Author:   Caroline J. Springer
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Edition:   2004 ed.
Volume:   90
Dimensions:   Width: 15.50cm , Height: 3.60cm , Length: 23.50cm
Weight:   2.220kg
ISBN:  

9780896039711

ISBN 10:   0896039714
Pages:   555
Publication Date:   04 November 2003
Audience:   College/higher education ,  Professional and scholarly ,  Undergraduate ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Introduction to the Background, Principles, and State of the Art in Suicide Gene Therapy Ion Niculescu-Duvaz and Caroline J. Springer Introduction to Vectors for Suicide Gene Therapy Caroline J. Springer Construction of VNP20009: A Novel, Genetically Stable Antibiotic-Sensitive Strain of Tumor-Targeting Salmonella for Parenteral Administration in Humans Kenneth Brooks Low, Martina Ittensohn, Xiang Luo, Li-Mou Zheng, Ivan King, John M. Pawelek, and David Bermudes Nonreplicating DNA Viral Vectors for Suicide Gene Therapy: The Adenoviral Vectors Masato Yamamoto and David T. Curiel Replication-Selective Oncolytic Adenoviruses Gunnel Halldén, Stephen H. Thorne, Jingping Yang, and David H. Kirn Retroviral Vectors for Suicide Gene Therapy Colin Porter Nonviral Liposomes Andrew D. Miller Peptide- and Polymer-Based Gene Delivery Vehicles Richard Brokx and Jean Gariépy Design of Prodrugs for Suicide Gene Therapy Dan Niculescu-Duvaz, Ion Niculescu-Duvaz, and Caroline J. Springer Cytochrome P450-Based Gene Therapies for Cancer E. Antonio Chiocca and David J. Waxman Tumor Sensitization to Purine Analogs by E. coli PNP Kimberly V. Curlee, William B. Parker, and Eric J. Sorscher Enzyme-Prodrug Systems: Carboxylesterase/CPT-11 Mary K. Danks and Philip M. Potter Enzyme-Prodrug Systems: Thymidine Phosphorylase/5'-Deoxy-5-Fluorouridine Alexandre Evrard, Joseph Ciccolini, Pierre Cuq, and Jean-Paul Cano Methods to Improve Efficacy in Suicide Gene Therapy Approaches: Targeting Prodrug-Activating Enzymes Carboxypeptidase G2 and Nitroreductase to Different Subcellular Compartments Silke Schepelmann, Robert Spooner, Frank Friedlos, and Richard Marais Extracellular b-Glucuronidase for Gene-Directed Enzyme-Prodrug Therapy Sabine Brüsselbach Enhancementof Suicide Gene Prodrug Activation by Random Mutagenesis Jean-Emmanuel Kurtz and Margaret E. Black Combination Suicide Gene Therapy Wolfgang Uckert, Brian Salmons, Christian Beltinger, Walter H. Günzburg, and Thomas Kammertöns Immune Response to Suicide Gene Therapy Shigeki Kuriyama, Hirohisa Tsujinoue, and Hitoshi Yoshiji Targeting Cancer With Gene Therapy Using Hypoxia as a Stimulus Gabi U. Dachs, Olga Greco, and Gillian M. Tozer Radiation-Activated Antitumor Vectors Simon D. Scott and Brian Marples In Vitro and In Vivo Models for the Evaluation of GDEPT: Quantifying Bystander Killing in Cell Cultures and Tumors William R. Wilson, Susan M. Pullen, Alison Hogg, Stephen M. Hobbs, Frederik B. Pruijn, and Kevin O. Hicks Suicide Gene Therapy in Liver Tumors Long R. Jiao, Roman Havlik, Joanna Nicholls, Steen Lindkaer Jensen, and Nagy A. Habib Clinical Trials With GDEPT: Cytosine Deaminase and 5-Fluorocytosine Nicola L. Brown and Nicholas R. Lemoine The Nitroreductase/CB1954 Enzyme-Prodrug System Nicola K. Green, David J. Kerr, Vivien Mautner, Peter A. Harris, and Peter F. Searle Side Effects of Suicide Gene Therapy Marjolijn M. van der Eb, Bertie de Leeuw, Alex J. van der Eb, and Rob C. Hoeben Antibody-Directed Enzyme-Prodrug Therapy R. Barbara Pedley, Surinder K. Sharma, Robert E. Hawkins, and Kerry A. Chester Bioreductive Prodrugs for Cancer Therapy Beatrice Seddon, Lloyd R. Kelland, and Paul Workman Index

Reviews

This is a good book for those working in the area of suicide gene therapy that can serve both as a reference to senior investigators as well as a primer to new lab members and researchers outside the field who are trying to get a flavor of the state of the field. - Doody's Health Sciences Book Review Journal

This is a good book for those working in the area of suicide gene therapy that can serve both as a reference to senior investigators as well as a primer to new lab members and researchers outside the field who are trying to get a flavor of the state of the field. -Doody's Health Sciences Book Review Journal ...an extensive review of the theoretical background of suicide gene therapy that covers all major aspects... - ChemBioChem Authoritative and up-to-date...provides the experimental means to advance its future development and therapeutic applications. - Anticancer Research

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions